Cargando…

Targeting Macrophage Dysregulation for Viral Infections: Novel Targets for Immunomodulators

A major barrier to human immunodeficiency virus (HIV-1) cure is the latent viral reservoir, which persists despite antiretroviral therapy (ART), including across the non-dividing myeloid reservoir which is found systemically in sanctuary sites across tissues and the central nervous system (CNS). Unl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reece, Monica D., Taylor, Ruby R., Song, Colin, Gavegnano, Christina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591232/ https://www.ncbi.nlm.nih.gov/pubmed/34790202 http://dx.doi.org/10.3389/fimmu.2021.768695

Ejemplares similares

Repurposing BCL-2 and Jak 1/2 inhibitors: Cure and treatment of HIV-1 and other viral infections
por: Reece, Monica D., et al.
Publicado: (2022)

Immunomodulation as a Novel Strategy for Prevention and Treatment of Bordetella spp. Infections
por: Gestal, Monica C., et al.
Publicado: (2019)

Editorial: Mycobacterial Glycolipids—Role in Immunomodulation and Targets for Vaccine Development
por: Källenius, Gunilla, et al.
Publicado: (2020)

The Impact of Macrophage Nucleotide Pools on HIV-1 Reverse Transcription, Viral Replication, and the Development of Novel Antiviral Agents
por: Gavegnano, Christina, et al.
Publicado: (2012)

Pulmonary Immune Dysregulation and Viral Persistence During HIV Infection
por: Alexandrova, Yulia, et al.
Publicado: (2022)

Trained immunity as a potential target for therapeutic immunomodulation in Duchenne muscular dystrophy
por: Petrof, Basil J., et al.
Publicado: (2023)

Helminth Immunomodulation in Autoimmune Disease
por: Smallwood, Taylor B., et al.
Publicado: (2017)

Dysregulation of Survivin-Targeting microRNAs in Autoimmune Diseases: New Perspectives for Novel Therapies
por: Shomali, Navid, et al.
Publicado: (2022)

Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities
por: Szabo, Attila
Publicado: (2015)

Macrophage–Neisseria gonorrhoeae Interactions: A Better Understanding of Pathogen Mechanisms of Immunomodulation
por: Escobar, Alejandro, et al.
Publicado: (2018)

Retraction: Dysregulation of survivin-targeting microRNAs in autoimmune diseases: new perspectives for novel therapies
Publicado: (2023)

Editorial: Soluble immune checkpoints: Novel physiological immunomodulators
por: Riva, Antonio
Publicado: (2023)

The role of AMPK in cancer metabolism and its impact on the immunomodulation of the tumor microenvironment
por: Keerthana, Chenicheri Kizhakkeveettil, et al.
Publicado: (2023)

Natural Killer Cell Immunomodulation: Targeting Activating, Inhibitory, and Co-stimulatory Receptor Signaling for Cancer Immunotherapy
por: Chester, Cariad, et al.
Publicado: (2015)

The Emerging Role of Triggering Receptor Expressed on Myeloid Cells 2 as a Target for Immunomodulation in Ischemic Stroke
por: Gervois, Pascal, et al.
Publicado: (2019)

Immunomodulation—a general review of the current state-of-the-art and new therapeutic strategies for targeting the immune system
por: Strzelec, Martyna, et al.
Publicado: (2023)

Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy
por: Eskandarian Boroujeni, Mahdi, et al.
Publicado: (2022)

Targeting Enclysis in Liver Autoimmunity, Transplantation, Viral Infection and Cancer
por: Aghabi, Yara O., et al.
Publicado: (2021)

Extracellular Purine Metabolism Is the Switchboard of Immunosuppressive Macrophages and a Novel Target to Treat Diseases With Macrophage Imbalances
por: Ohradanova-Repic, Anna, et al.
Publicado: (2018)

Crossroads of Cancer and HIV-1: Pathways to a Cure for HIV
por: Gavegnano, Christina, et al.
Publicado: (2019)

Immunomodulation by the Commensal Microbiome During Immune-Targeted Interventions: Focus on Cancer Immune Checkpoint Inhibitor Therapy and Vaccination
por: Reens, Abigail L., et al.
Publicado: (2021)

Dysregulation of Complement Activation and Placental Dysfunction: A Potential Target to Treat Preeclampsia?
por: Pierik, E., et al.
Publicado: (2020)

Proteomics of Mycobacterium Infection: Moving towards a Better Understanding of Pathogen-Driven Immunomodulation
por: Hoffmann, Eik, et al.
Publicado: (2018)

Targeting Inflammation to Reduce Atherosclerotic Cardiovascular Risk in People With HIV Infection
por: Titanji, Boghuma, et al.
Publicado: (2020)

Editorial: The role of vitamin D as an immunomodulator
por: Aribi, Mourad, et al.
Publicado: (2023)

Clostridial C3 Toxins Target Monocytes/Macrophages and Modulate Their Functions
por: Barth, Holger, et al.
Publicado: (2015)

Park 7: A Novel Therapeutic Target for Macrophages in Sepsis-Induced Immunosuppression
por: Cheng, Yanwei, et al.
Publicado: (2018)

Immunomodulation by Helminths: Intracellular Pathways and Extracellular Vesicles
por: Zakeri, Amin, et al.
Publicado: (2018)

Editorial: Immunomodulation of Innate Immune Cells
por: Almeida, Catarina R., et al.
Publicado: (2020)

Targeting of Hepatic Macrophages by Therapeutic Nanoparticles
por: Colino, Clara I., et al.
Publicado: (2020)

Macrophage Foam Cell-Targeting Immunization Attenuates Atherosclerosis
por: Wang, Fazhan, et al.
Publicado: (2019)

Origin, activation, and targeted therapy of glioma-associated macrophages
por: Xu, Can, et al.
Publicado: (2022)

Targeting T cell (oxidative) metabolism to improve immunity to viral infection in the context of obesity
por: Greene, Elizabeth, et al.
Publicado: (2022)

Intravenous Immunoglobulin and Immunomodulation of B-Cell – in vitro and in vivo Effects
por: Mitrevski, Milica, et al.
Publicado: (2015)

Brucella Dysregulates Monocytes and Inhibits Macrophage Polarization through LC3-Dependent Autophagy
por: Wang, Yang, et al.
Publicado: (2017)

Dysregulated monocyte-derived macrophage response to Group B Streptococcus in newborns
por: Ravi, Denho, et al.
Publicado: (2023)

A Role for Epitope Networking in Immunomodulation by Helminths
por: Homan, E. Jane, et al.
Publicado: (2018)

Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics
por: Kotraiah, Vinayaka, et al.
Publicado: (2020)

RIG-I-Like Receptors as Novel Targets for Pan-Antivirals and Vaccine Adjuvants Against Emerging and Re-Emerging Viral Infections
por: Yong, Hui Yee, et al.
Publicado: (2018)

HP-NAP of Helicobacter pylori: The Power of the Immunomodulation
por: Codolo, Gaia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_95vob183f3a2m2s6o6kinuo8r2